These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 306035)

  • 1. [Hypertension in old age (author's transl)].
    Holzgreve H
    MMW Munch Med Wochenschr; 1978 Mar; 120(13):445-8. PubMed ID: 306035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence, natural history and complications of chronic arterial hypertension (author's transl)].
    Holzgreve H
    Herz; 1978 Aug; 3(4):229-34. PubMed ID: 721051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of control of high blood pressure and treatment recommendations in Canada.
    Khan N; Chockalingam A; Campbell NR
    Can J Cardiol; 2002 Jun; 18(6):657-61. PubMed ID: 12107423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertension, over-weight and age: early treatment of hypertension (a factory survey) (author's transl)].
    Kornhuber HH; Lisson G
    Dtsch Med Wochenschr; 1981 Dec; 106(50):1692-6. PubMed ID: 7308012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension in the elderly: new and old evidence that treatment may benefit the old.
    Fagard RH
    J Nephrol; 2009; 22(5):580-6. PubMed ID: 19809990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive treatment alters the predictive strength of pulse pressure and other blood pressure measures.
    Greenberg J
    Am J Hypertens; 2005 Aug; 18(8):1033-9. PubMed ID: 16109316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of first antihypertensive: simple as ABCD?
    Mahmud A; Feely J
    Am J Hypertens; 2007 Aug; 20(8):923-7. PubMed ID: 17679044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should treatment of mild to moderate hypertension be targeted? Results from a Markov cohort model incorporating multiple risk factors.
    Kawachi I; Purdie G
    J Hum Hypertens; 1990 Dec; 4(6):651-8. PubMed ID: 2151391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [When can the treatment of isolated systolic hypertension be avoided?].
    Vischer UM; Benetos A
    Rev Med Suisse; 2006 Apr; 2(60):942-6. PubMed ID: 16673726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care.
    Samuelsson O
    Acta Med Scand Suppl; 1985; 702():1-79. PubMed ID: 3866485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
    Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Profile of the treated elderly hypertensive patient].
    Román O; Badilla M; Valenzuela A; Cumsille F; Rodríguez N
    Rev Med Chil; 2002 Jun; 130(6):616-22. PubMed ID: 12194683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of treatments for hypertension in a sample of Colombian patients].
    Isaza CA; Moncada JC; Mesa G; Osorio FJ
    Biomedica; 2004 Sep; 24(3):273-81. PubMed ID: 15551879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
    Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
    Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.